RT @ethanjweiss: New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN

RT @ethanjweiss: New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN

New Cochrane Review on Ruxolitinib in myelofibrosis. It is not favorable... https://t.co/cnXJhmk7eN

Cochrane: Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis http://t.co/SdnkAcPujv

First Cochrane review using Epistemonikos!! http://t.co/zCWONp7jBa Good news! Now let's hope others follow them.

MT @epistemonikos: First Cochrane review using Epistemonikos!! http://t.co/NHl0NbL0jN Kudos to Arturo Martí, @IvanSola and their team.

MT @epistemonikos: First Cochrane review using Epistemonikos!! http://t.co/NHl0NbL0jN Kudos to Arturo Martí, @IvanSola and their team.

“@epistemonikos: First Cochrane review using Epistemonikos!! http://t.co/QLI9SImQy0 Good Job! @IvanSola

“@epistemonikos: First Cochrane review using Epistemonikos!! http://t.co/TZQ4KNrafG Good Job! @IvanSola

First Cochrane review using Epistemonikos!! http://t.co/zCWONp7jBa Good news! Now let's hope others follow them.